Brind.
  1. Medical device sales are up in the U.S., but major players like J&J are facing market headwinds due to the VBP program in China.

MedTech is identified as a soft spot in J&J case.

2 reports, 2 independent Updated Aug 27
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

MedTech is identified as a soft spot in J&J case.

Who's involved

What this event is mainly about
Johnson & JohnsonMedtech

Keep exploring

Part of

Medical device sales are up in the U.S., but major players like J&J are facing market headwinds due to the VBP program in China. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped